More about

Chronic Kidney Failure

News
April 11, 2022
3 min read
Save

CANTOS: Inflammation strong predictor of recurrent CV events in CKD

WASHINGTON — Among adults with atherosclerotic CVD and impaired kidney function, residual inflammation is a stronger predictor of recurrent CV events than hyperlipidemia, particularly for CV and all-cause mortality, researchers reported.

News
April 06, 2022
1 min read
Save

NKF announces Medical Advisory Board Distinguished Service Award winner

Amy Wilson, MD, pediatric nephrologist at Indiana University School of Medicine and Riley Children’s Hospital, will receive the Medical Advisory Board Distinguished Service Award from the National Kidney Foundation.

News
March 14, 2022
1 min read
Save

Penn Medicine enters joint venture with Evergreen Nephrology

The University of Pennsylvania Health System has created and entered a joint venture with Evergreen Nephrology to improve kidney outcomes while containing costs of care, according to a press release.

News
March 10, 2022
3 min read
Save

On World Kidney Day, efforts are underway to improve detection of CKD

Today is World Kidney Day, and the National Kidney Foundation is emphasizing its effort with the Coalition for Kidney Health to nominate targeted screening or case finding for chronic kidney disease based on risk conditions, like diabetes.

News
February 08, 2022
1 min read
Save

Dialyze Direct intends to acquire Compass Home Dialysis

Dialyze Direct announced it has signed a letter of intent to obtain Compass Home Dialysis on or before Feb. 28, 2022.

News
January 26, 2022
2 min read
Save

Removing race-specific coefficient in eGFR equation impacts CKD trial inclusion

Removing the race-specific coefficient from the equation that determines eGFR results in a “small but potentially important” effect on the inclusion of patients in [chronic kidney disease] trials, according to published data.

News
November 06, 2021
1 min read
Save

New data show empagliflozin slows GFR, maintains ejection fraction in CKD, heart failure

Patients with chronic kidney disease and heart failure who took the sodium glucose co-transporter 2 inhibitor empagliflozin saw a stabilization of ejection fraction and a slowing in eGFR decline, according to trial results presented here.

News
November 06, 2021
1 min read
Save

Greater kidney function recovery with avacopan in patients with ANCA-associated vasculitis

Patients with ANCA-associated vasculitis who received avacopan showed greater recovery of kidney function compared with patients who received prednisone, according to study results presented at ASN Kidney Week.

News
September 11, 2021
3 min read
Save

Anti-arrhythmic effects of SGLT2 inhibitors 'may be an alias for improving heart failure'

SGLT2 inhibitors may directly or indirectly impact factors associated with diabetes and atrial fibrillation/atrial flutter, according to a speaker at the Heart in Diabetes CME Conference.

News
July 22, 2021
1 min read
Save

Strong social support linked to more positive clinical outcomes among patients with CKD

Older patients with chronic kidney disease and a strong social support system are more likely to have a higher quality of life, experience less frailty and exhibit better cognitive function, a study appearing in Kidney Medicine revealed.

View more